Earnings4967KOBAYASHI PHARMACEUTICAL CO.,LTD.
Kobayashi Pharmaceutical Reports Q1 Revenue of 33.7 billion, Up 3%
TOKYO, May 08 (Pulse News Wire) – Kobayashi Pharmaceutical Co., Ltd. (4967.T) reported consolidated results for Q1 FY2026 (ending December 2026).
Revenue was ¥33.7 billion (+3.2% YoY). operating profit was ¥1,350 million (-46.7%). net profit attributable to shareholders was ¥1,036 million (-36.2%).
Total assets stood at ¥250 billion with an equity ratio of 81.7%. The company declared an annual dividend of ¥61 per share. The full-year forecast for the current fiscal year is revenue of ¥170 billion (+4.4%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥33,665M | +3.2% |
| Operating profit | ¥1,350M | -46.7% |
| Net profit | ¥1,036M | -36.2% |
Next period forecast
Revenue
¥173,000M
+4.4%Op. profit
¥12,500M
-16.2%Net profit
¥10,000M
+173.5%Figures in millions of yen
End of article